{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:40:18Z","timestamp":1777876818332,"version":"3.51.4"},"reference-count":146,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Department of Medical Oncology at CHU de Li\u00e8ge"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Med Oncol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Synthetic lethality (SL) is a promising therapeutic concept that relies on the indirect targeting of vulnerabilities acquired through genetic mutations. Ovarian and endometrial cancers frequently exhibit mutations in the breast cancer (BRCA), phosphatase and tensin homolog (PTEN), AT-rich interactive domain-containing protein 1A (ARID1A) and TP53 genes, as well as DNA repair pathway deficiencies. Poly(ADP-ribose) polymerase inhibitors (PARPis) have demonstrated remarkable efficacy in various cancers with BRCA mutations and homologous recombination deficiency. In addition to PARPi, there has been an expansion of drugs exploiting the selective vulnerability of cancer cells via SL, such as WEE1 kinase and Ataxia Telangiectasia and Rad3-related protein (ATR). WEE1 inhibitors have shown encouraging results in combination with chemotherapy, increasing the objective response rate in patients with platinum-resistant TP53-mutated ovarian cancer. ATR inhibitors are currently being evaluated in ARID1A-mutated tumours, with preliminary results confirming their therapeutic potential.<\/jats:p>","DOI":"10.1177\/17588359251392106","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:40:15Z","timestamp":1764934815000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting synthetic lethality: an effective therapeutic approach in ovarian and endometrial cancers"],"prefix":"10.1177","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-3232","authenticated-orcid":false,"given":"Aliz\u00e9e","family":"Lebeau","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"},{"name":"Department of Gynaecology and Obstetrics, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Kakkos","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Leroi","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bours","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katty","family":"Delbecque","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Goffin","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Gonne","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHU of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-6219","authenticated-orcid":false,"given":"Christine","family":"Gennigens","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHU of Li\u00e8ge, Avenue de l\u2019H\u00f4pital 1, 4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12113"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10166"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008433"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt384"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13837"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102790"},{"issue":"1","key":"e_1_3_4_8_2","first-page":"1","article-title":"Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes","volume":"8","author":"Truesdell P","year":"2024","unstructured":"Truesdell P, Chang J, Coto Villa D, et al. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes. NPJ Precis Oncol 2024; 8(1): 1\u201313.","journal-title":"NPJ Precis Oncol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202254742"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21544-2"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2017.47"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5340.1064"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8888"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900212"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-018-0008-7"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1606"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-32"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1198"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05953"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2189"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16078-y"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.19.8504-8518.2004"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5472"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01121-10"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2352"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27776"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0587"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.78091"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.09.014"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01557-x"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103987"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.356"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7118"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.012"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.05.008"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.961611"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"issue":"1","key":"e_1_3_4_41_2","first-page":"1","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang R","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther 2021; 6(1): 1\u201335.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25103"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3822"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.48"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01900-9"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0714"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02122-9"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1443"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0152-0"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03917-2"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2019.07.008"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00001"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4032"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507075200"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.09.003"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2273"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17127-2"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50151-y"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00863-5"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0361"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1562"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196333"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3068"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0849"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae233"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12146"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009238"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.144"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3799"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00856-5"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155899"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140918824"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.036"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12868-5"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01259-6"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.169"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0654-8"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000243"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05527-y"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.024"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.573"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1815309"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.09.043"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.774845"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2247"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100394"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1564"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24987"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00404-3"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210518"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.03.010"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0954-x"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101458"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.01.033"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113178"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2007.24"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0015-0"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712169105"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401734R"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919849753"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00122-X"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2018.08.021"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01549"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2241"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.05.005"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00086-8"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004995"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2269"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.08.021"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00073-5"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103538"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02132"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13349"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004079"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-022-00747-1"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0301"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-CT007"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25904-w"},{"key":"e_1_3_4_123_2","article-title":"Randomized phase II study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: final overall survival and biomarker analyses","volume":"8","author":"Konstantinopoulos PA","year":"2024","unstructured":"Konstantinopoulos PA, Cheng SC, Lee EK, et al. Randomized phase II study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: final overall survival and biomarker analyses. JCO Precis Oncol 2024; 8: e2300635.","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.5510"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2444"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002973"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.100814"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_4_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.05.063"},{"key":"e_1_3_4_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32554-X"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0158"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.5515"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0219"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.5505"},{"key":"e_1_3_4_135_2","article-title":"PR072\/#1519 effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316)","volume":"33","author":"Adjei N","year":"2023","unstructured":"Adjei N, Coleman R, Fellman B, et al. PR072\/#1519 effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316). Int J Gynecol Cancer 2023; 33: A71\u2013A73.","journal-title":"Int J Gynecol Cancer"},{"key":"e_1_3_4_136_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03167"},{"key":"e_1_3_4_137_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-003144"},{"key":"e_1_3_4_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.06.512"},{"key":"e_1_3_4_139_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.5513"},{"key":"e_1_3_4_140_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2380-5"},{"key":"e_1_3_4_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.09.019"},{"key":"e_1_3_4_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30009-3"},{"key":"e_1_3_4_143_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02279-x"},{"key":"e_1_3_4_144_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy076"},{"key":"e_1_3_4_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0733-6"},{"key":"e_1_3_4_146_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4286"},{"key":"e_1_3_4_147_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4225"}],"container-title":["Therapeutic Advances in Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359251392106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17588359251392106","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359251392106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:33:43Z","timestamp":1777588423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17588359251392106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":146,"alternative-id":["10.1177\/17588359251392106"],"URL":"https:\/\/doi.org\/10.1177\/17588359251392106","relation":{},"ISSN":["1758-8359","1758-8359"],"issn-type":[{"value":"1758-8359","type":"print"},{"value":"1758-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"article-number":"17588359251392106"}}